Venu Holding Corporation
Venu Holding Corporation (VENU) Financial Performance & Income Statement Overview
Analyze Venu Holding Corporation (VENU) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Venu Holding Corporation (VENU) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Venu Holding Corporation VENU financial performance.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $2.04M | $4.27M | $5.45M | $4.18M |
Cost of Revenue | $1.86M | $2.75M | $2.58M | $2.90M |
Gross Profit | $183752.00 | $1.52M | $2.88M | $1.27M |
Gross Profit Ratio | $0.09 | $0.36 | $0.53 | $0.30 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $6.74M | $18.19M | $0.00 | $421678.00 |
Operating Expenses | $6.74M | $6.95M | $6.55M | $5.62M |
Total Costs & Expenses | $8.60M | $10.65M | $9.13M | $8.53M |
Interest Income | $127486.00 | $202767.00 | $276452.00 | $200779.00 |
Interest Expense | -$1.05M | $1.19M | $1.16M | $1.15M |
Depreciation & Amortization | $1.38M | $1.34M | $1.10M | $609329.00 |
EBITDA | -$17.17M | -$6.00M | -$2.26M | -$3.51M |
EBITDA Ratio | -$8.39 | -$1.41 | -$0.41 | -$0.84 |
Operating Income | -$18.54M | -$6.38M | -$3.68M | -$4.35M |
Operating Income Ratio | -$9.07 | -$1.50 | -$0.67 | -$1.04 |
Other Income/Expenses (Net) | $478634.00 | -$953462.00 | -$851211.00 | -$916942.00 |
Income Before Tax | -$18.06M | -$7.34M | -$4.53M | -$5.27M |
Income Before Tax Ratio | -$8.83 | -$1.72 | -$0.83 | -$1.26 |
Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
Net Income | -$18.06M | -$6.29M | -$3.93M | -$4.52M |
Net Income Ratio | -$8.83 | -$1.47 | -$0.72 | -$1.08 |
EPS | -$0.48 | -$0.17 | -$0.11 | -$0.12 |
Diluted EPS | -$0.48 | -$0.17 | -$0.11 | -$0.12 |
Weighted Avg Shares Outstanding | $38.00M | $37.47M | $37.16M | $37.66M |
Weighted Avg Shares Outstanding (Diluted) | $38.00M | $37.47M | $37.16M | $37.66M |
Over the past four quarters, Venu Holding Corporation demonstrated steady revenue growth, increasing from $4.18M in Q2 2024 to $2.04M in Q1 2025. Operating income reached -$18.54M in Q1 2025, maintaining a consistent -907% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$17.17M, reflecting operational efficiency. Net income dropped to -$18.06M, with EPS at -$0.48. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan